Negative feedback loop of bone resorption by NFATc1-dependent induction of Cadm1.

Trimethylation of histone H3 lysine 4 and lysine 27 (H3K4me3 and H3K27me3) at gene promoter regions critically regulates gene expression. Key developmental genes tend to exhibit changes in histone modification patterns from the H3K4me3/H3K27me3 bivalent pattern to the H3K4me3 monovalent pattern. Using comprehensive chromatin immunoprecipitation followed by sequencing in bone marrow-derived macrophages (BMMs) and mature osteoclasts, we found that cell surface adhesion molecule 1 (Cadm1) is a direct target of nuclear factor of activated T cells 1 (NFATc1) and exhibits a bivalent histone pattern in BMMs and a monovalent pattern in osteoclasts. Cadm1 expression was upregulated in BMMs by receptor activator of nuclear factor kappa B ligand (RANKL), and blocked by a calcineurin/NFATc1 inhibitor, FK506. Cadm1-deficient mice exhibited significantly reduced bone mass compared with wild-type mice, which was due to the increased osteoclast differentiation, survival and bone-resorbing activity in Cadm1-deficient osteoclasts. These results suggest that Cadm1 is a direct target of NFATc1, which is induced by RANKL through epigenetic modification, and regulates osteoclastic bone resorption in a negative feedback manner.

Introduction

Skeletal homeostasis is maintained in the balance between bone r<span class="Disease">esorption and bone formation. Osteoclasts (OCs) are multinucleated cells derived from monocyte/macrophage-lineage precursor cells and are primarily responsible for bone resorption [1]. Receptor activator of nuclear factor kappa B ligand (RANKL), a member of the tumor necrosis factor superfamily of cytokines, is indispensable for osteoclast differentiation [2], and its deficiency abrogates osteoclastogenesis and leads to osteopetrosis [3, 4]. RANKL binds to its receptor RANK and activates a wide range of intracellular signaling cascades that activate nuclear factor of activated T cells 1 (NFATc1), a transcription factor essential for osteoclast differentiation [5-7].

Epigenetic regulation of gene expression through post-translational modification of histone proteins by methylation and/or acetylation plays an important role in various processes such as cell cycle regulation, embryonic development and cellular differentiation [8]. Trimethylation of histone H3 at lysine 4 (H3K4me3) is mainly localized at gene promoter regions and is correlated with transcriptional activation, while trimethylation of H3 lysine 27 (H3K27me3) is involved in polycomb-mediated gene repression [9, 10]. Bernstein et al. reported that changes in the histone modification status in embryonic stem cells from H3K4me3/H3K27me3 bivalent patterns to H3K4me3 monovalent patterns by H3K27 demethylation are associated with active gene expression [11]. We previously demonstrated the bivalent to monovalent change of histone methylation at the promoter region of the NFATc1 gene during RANKL-induced osteoclastogenesis using chromatin immunoprecipitation followed by sequencing (ChIP-seq) [12]. NFATc1 is induced by RANKL stimulation downstream of calcium/calcineurin signaling [13], and plays key roles in osteoclastogenesis by regulating the expression of various osteoclast-related genes, such as Nfatc1 itself, Cathepsin K (Ctsk) and dendritic cell-specific transmembrane protein (Dc-stamp) [14-16].

<span class="Gene">Cell adhesion molecule 1 (<span class="Gene">CADM1), also known as IGSF4 (immunoglobulin superfamily 4), NECL2 (Nectin-like molecule 2), SynCAM1 (synaptic cell adhesion molecule 1), sgIGSF (spermatogenic immunoglobulin superfamily) or TSLC1 (tumor suppressor in lung cancer 1), is a member of the immunoglobulin superfamily. A missense mutation in the CADM1 gene was reported in some patients with autism [17-23]. CADM1 was originally identified as a tumor suppressor gene that suppressed tumor growth in nude mice and suppressed cancer metastasis by regulating cell adhesion [24]. Cadm1 knockout (KO) mice exhibited oligoasthenoteratozoospermia and impaired social/emotional behaviors [25, 26]. However, no skeletal phenotypes in Cadm1 KO mice have been reported.

In this study, we explored <span class="Gene">NFATc1 target gen<span class="Disease">es whose histone methylation status at the promoter regions changed from bivalent to monovalent patterns.

Materials and methods

Reagents

<span class="Chemical">Alpha-minimum essential medium (α-MEM) and fetal <span class="Species">bovine serum (FBS) were purchased from Life Technologies (Carlsbad, CA, USA). Recombinant human M-CSF was purchased from R&D Systems (Minneapolis, MN, USA), and GST-RANKL was purchased from Oriental Yeast Co., Ltd (Shiga, Japan). Anti-trimethyl-histone H3 lysine 4 and anti-trimethyl-histone H3 lysine 27 were from Active Motif (rabbit polyclonal antibody, 39159, Carlsbad, CA, USA) and Millipore (rabbit polyclonal antibody, 07–449, Billerica, MA, USA), respectively. Anti-NFATc1 antibody detects all DNA binding domain-containing NFATc1 splicing isoforms, but not the closely related NFATc2 [27]. Anti-FAK, anti-Pyk2 and anti-Src antibodies were from Cell Signaling Technology (rabbit polyclonal antibody; Beverly, MA, USA).

Animal models

Wild-type <span class="Species">mice on a C57BL/6 background were purchased from Sankyo Labo Service (Tokyo, Japan). <span class="Gene">Cadm1 KO mice on a C57BL/6 background were generated as described [25, 26]. Mice were housed in individually ventilated cages with paper bedding and provided standard rodent maintenance diet and water throughout the study. At the studies, mice were euthanized by cervical dislocation. Ethics committee Institutional Care and Use Committee (IACUC) in the University of Tokyo specifically approved this study (P14-096).

Cell culture

<span class="Species">Murine bone marrow cells were isolated from the femur and tibia of male <span class="Species">mice at 7–9 weeks of age. To prepare bone marrow macrophages (BMMs), cells were cultured in α-MEM/10% FBS with 50 ng/ml M-CSF for 2 days. BMMs were further cultured in the presence of 50 ng/ml M-CSF and 25 ng/ml RANKL for 3–5 days to generate osteoclasts.

To detect actin rings, cells were incubated for 30 min with <span class="Chemical">rhodamine-conjugated <span class="Chemical">phalloidin solution (Molecular Probes, Inc., Eugene, OR, USA) and observed under a fluorescence microscope (BZ-8100, Keyence).

ChIP-seq

Cells were fixed with 1% formaldehyde at room temperature and then neutralized with glycine. Samples were then sonicated and incubated with protein A/G beads that had been pre-incubated with 4–10 μg of antibody. Immunoprecipitates were washed and reverse-crosslinked, and samples were then DNA purified using a PCR purification kit (Qiagen GmbH, Hilden, Germany). DNA libraries were prepared for sequencing using the standard Illumina protocol. Purified DNA was applied for cluster generation and sequencing was performed using the cBot Cluster Generation system and Genome Analyzer IIx system (Illumina; San Diego, CA, USA), following the manufacturer’s instructions. Obtained sequences were mapped to the reference mouse genome.

RNA-seq

Total RNA was extracted using ISOGEN (Nippon Gene, Tokyo, Japan) from BM<span class="Disease">Ms or OCs following the manufacturer’s protocol. Librari<span class="Disease">es were made using TruSeq RNA Sample Preparation Kits (Illumina), according to the manufacturer’s instructions. RNA sequencing was performed using the Illumina Genome Analyzer IIx.

Analysis of bone mineral density (BMD) and skeletal morphology

Eight-week-old male wild-type or <span class="Gene">Cadm1 KO <span class="Species">mice were subcutaneously injected with 10 mg/kg body weight of calcein on 4 days and 1 day before sacrifice. Hindlimbs were removed, fixed with 70% ethanol, and subjected to a dual energy x-ray absorptiometric scan analysis to measure BMD (mg/cm2) using the DCS-600R system (Aloka Co. Ltd, Tokyo, Japan). Hindlimbs were then undecalcified, embedded in glycol methacrylate, cut into 3 μm sections longitudinally in the proximal region of the tibia, and stained with toluidine blue O or tartrate-resistant acid phosphatase (TRAP). For TRAP staining, tissue slices were stained at pH 5.0 in the presence of L (+)-tartaric acid using naphthol AS-MX phosphate (Sigma-Aldrich) in N,N-dimethyl formamide as substrate. Histomorphometric measurement was performed in stained sections from the secondary spongiosa area, 1.05 mm from the growth plate and 0.4 mm from the end of metaphysis, using OsteoMeasure software (OsteoMetrics, Inc., Decatur, GA).

Bone resorption assay

Osteoclasts were cultured on dentine slic<span class="Disease">es. R<span class="Disease">esorption areas were visualized by staining with 1% toluidine blue and then measured under a microscope (BZ-8100).

Survival assay

Once osteoclasts were generated, <span class="Gene">RANKL and <span class="Gene">M-CSF were removed from the culture medium (at a time defined as time 0), and cells were cultured for the time periods indicated in the text. Survival was calculated by dividing the number of morphologically intact TRAP+ multinucleated cells by those present at time 0.

Real-time PCR analysis

Total RNA was extracted with an RNeasy mini kit (Qiagen GmbH, Hilden, Germany) and reverse transcription was performed using a Prime Script RT reagent kit (Takara Bio) according to the manufacturer’s instructions. Realtime PCR was performed with a Thermal Cycler Dice Real-Time System using SYBR Premix Ex Taq (Takara Bio). All reactions were performed in triplicate. Relative mRNA expr<span class="Disease">ession levels were normalized to that of <span class="Species">mouse β-actin.

Primer sequenc<span class="Disease">es were as follows:

Western blotting

Cells were washed with ice-cold PBS and lysed at 4°C with RIPA buffer (1% Tween20, 0.1% SDS, 150 mM NaCl, 10 mM Tris-HCl (pH 7.4), 0.25 mM phenylmethylsulfonyl fluoride, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mM Na3VO4, and 5 mM NaF (Sigma)). Proteins were subjected to SDS-PAGE on 7.5–15% Tris-Glycine gradient gels or 15% Tris-Glycine gels and transferred onto PVDF membranes (Millipore Corp.). After blocking, membranes were incubated with primary antibodies to FAK, Pyk2, and Src (Cell Signaling Technology) or Actin (Sigma-Aldrich), followed by HRP-conjugated goat anti-rabbit IgG (Promega). Immunoreactive bands were visualized by ECL (GE Healthcare) according to the manufacturer’s instructions. Blots were stripped by a 30-min incubation in buffer (2% SDS, 100 mM 2-mercaptoethanol, and 62.5 mM Tris-HCl, pH 6.7) at 50°C and then re-probed with other antibodies.

Statistical analysis

Data are pr<span class="Disease">esented as means ± SD. Statistical analys<span class="Disease">es were performed using a two-tailed unpaired Student’s t-test.

Results

Cadm1 exhibits changes from the H3K4me3/H3K27me3 bivalent to the H3K4me3 monovalent pattern and is an NFATc1 target in osteoclasts

We first identified gen<span class="Disease">es that exhibited H3K4me3/H3K27me3 bivalent patterns at the promoter region in BM<span class="Disease">Ms and H3K4me3 monovalent patterns in mature osteoclasts by comprehensive ChIP-seq analysis using anti-H3K4me3 and anti-H3K27me3 antibodies, as previously described [12, 28, 29]. We selected 49 genes that showed the change of the histone methylation pattern within 5 kb of transcriptional start sites (TSSs), which are putative promoter regions. We also performed ChIP-seq using anti-NFATc1 antibody, and found that 33 genes among the 49 genes exhibited NFATc1 binding at the promoter regions in osteoclasts. These genes included representative osteoclast-specific genes, such as Nfatc1 and carbonic anhydrase 2 (Car2) (Table 1) [14, 30].

Table 1

Genes whose histone modification pattern changes from bivalent to monovalent during osteoclastogenesis and with NFATc1 binding near the transcription start site.

4930506M07Rik	D10Bwg1379e	Rab34
Adcy3	Edil3	Rab38
Arhgef12	Fbxo32	Rnd1
Atrnl1	Lgals3	Rps6ka2
Bahd1	Met	Rusc2
Cadm1	Msi2	Sdc1
Car2	Myo1d	Sh3bgrl2
Cd109	Nfatc1	Tmcc3
Cd97	Plxna2	Tspan17
Cdyl2	Plxnd1	Vegfa
Cgnl1	Ppap2a	Zfp462

Among the 33 identified gen<span class="Disease">es, we focused on <span class="Gene">Cadm1, which encodes a cell adhesion molecule belonging to the immunoglobulin superfamily [24]. Immunoglobulin superfamily proteins played a critical role in RANKL-induced osteoclastogenesis by regulating intracellular calcium signaling [31]. In addition, members such as intercellular adhesion molecule-1 (ICAM1) played critical roles in osteoclast function [31]. Therefore, Cadm1 may regulate osteoclast differentiation and function via its immunoglobulin-like motifs. Histone modifications at the Cadm1 promoter changed from H3K4me3/H3K27me3 bivalent patterns in BMMs to H3K4me3 monovalent patterns in response to RANKL (Fig 1A). NFATc1 binding at the Cadm1 promoter in osteoclasts was detected by ChIP-seq (Fig 1A), confirming our selection criteria. Real-time PCR analysis revealed that Cadm1 expression was greatly increased during RANKL-stimulated osteoclastogenesis and positively correlated with elevated expression of Ctsk, a marker of osteoclast differentiation (Fig 1B). RANKL-dependent Cadm1 upregulation in osteoclasts was blocked by treatment of cells with a calcium/calcineurin signaling inhibitor, FK506, confirming that Cadm1 is an NFATc1 target (Fig 1C).

Fig 1

Epigenetic regulation and expression of Cadm1 during osteoclastogenesis.

(A) ChIP-seq analysis of H3K4me3, H3K27me3 and NFATc1 near the Cadm1 transcription start site (TSS). (B and C) Expression of Cadm1 and Ctsk mRNAs relative to that of β-actin in BMMs cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) with or without FK506 (1 μM) for indicated periods. Data represent mean Cadm1 or Ctsk expression relative to β-actin ± SD (*P < 0.05; n = 3).

(A) ChIP-seq analysis of H3K4me3, H3K27me3 and <span class="Gene">NFATc1 near the <span class="Gene">Cadm1 transcription start site (TSS). (B and C) Expression of Cadm1 and Ctsk mRNAs relative to that of β-actin in BMMs cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) with or without FK506 (1 μM) for indicated periods. Data represent mean Cadm1 or Ctsk expression relative to β-actin ± SD (*P < 0.05; n = 3).

Cadm1 KO mice exhibit decreased bone mass

We next analyzed the skeletal tissue of <span class="Gene">Cadm1 KO <span class="Species">mice. Cadm1 KO mice showed a significant reduction in bone mass compared with wild-type mice (Fig 2A). Bone morphometric analysis revealed that Cadm1 KO mice exhibited reduced BV/TV and Tb.N and elevated Tb.Sp (Fig 2B and 2C). In contrast, osteoclast parameters, such as ES/BS, Oc.S/BS and N.Oc/BS, or osteoblast parameters, such as Ob.S/BS, MS/BS and BFR, were not significantly different between wild-type and KO mice (Fig 2B and 2C).

Fig 2

Cadm1 KO mice exhibit decreased bone mineral density.

(A) Bone mineral density (BMD) of femurs from male wild-type or Cadm1 KO mice (*P < 0.05; **P < 0.005; n = 5). (B) Representative toluidine blue O staining (top) and TRAP staining (bottom) images of proximal tibias from male wild-type (left) or Cadm1 KO (right) mice. Bars, 100 μm. (C) Bone morphometric analysis of 8-week-old wild-type or Cadm1 KO mice. BV/TV, bone volume per total volume; Tb.Th, trabecular thickness; Tb.N, trabecular number; Tb.Sp, trabecular separation; ES/BS, eroded surface per bone surface; Oc.S/BS, osteoclast surface per bone surface; N.Oc/BS, osteoclast number per bone surface; Ob.S/BS, osteoblast surface per bone surface; MS/BS, mineralizing surface per bone surface; BFR/BS, bone formation rate per bone surface. Data represent mean value of the indicated parameter ± SD (#P < 0.1; *P < 0.05; n = 5).

(A) Bone mineral density (BMD) of femurs from male wild-type or <span class="Gene">Cadm1 KO <span class="Species">mice (*P < 0.05; **P < 0.005; n = 5). (B) Representative toluidine blue O staining (top) and TRAP staining (bottom) images of proximal tibias from male wild-type (left) or Cadm1 KO (right) mice. Bars, 100 μm. (C) Bone morphometric analysis of 8-week-old wild-type or Cadm1 KO mice. BV/TV, bone volume per total volume; Tb.Th, trabecular thickness; Tb.N, trabecular number; Tb.Sp, trabecular separation; ES/BS, eroded surface per bone surface; Oc.S/BS, osteoclast surface per bone surface; N.Oc/BS, osteoclast number per bone surface; Ob.S/BS, osteoblast surface per bone surface; MS/BS, mineralizing surface per bone surface; BFR/BS, bone formation rate per bone surface. Data represent mean value of the indicated parameter ± SD (#P < 0.1; *P < 0.05; n = 5).

Cadm1 KO osteoclasts show enhanced differentiation and bone-resorbing function

To analyze the possible function of <span class="Gene">Cadm1 in osteoclasts, we isolated osteoclast progenitor cells from <span class="Gene">Cadm1 KO and wild-type mice and cultured them in the presence of M-CSF and RANKL (Fig 3). Osteoclast differentiation as analyzed by multinucleated TRAP-positive cell formation did not differ between Cadm1 KO and wild-type cells (Fig 3A). In addition, nuclear localization of Nfatc1 was not different between cadm1-deficient and wild-type osteoclasts (S1 Fig). However, real-time PCR analysis indicated that expressions of osteoclast-specific genes such as Nfatc1, Ctsk, acid phosphatase 5, tartrate resistant (Acp5) and Dc-stamp were slightly but significantly higher in Cadm1 KO osteoclasts as compared with wild-type cells (Fig 3B). In addition, Cadm1 KO osteoclasts were more resistant to cytokine depletion-induced cell death as compared with wild-type osteoclasts (Fig 3C). Furthermore, bone-resorbing activity, as evaluated by pit formation on dentine slices, was significantly higher in Cadm1 KO osteoclasts than wild-type osteoclasts (Fig 3D). Overall, these results suggest that Cadm1 negatively regulates osteoclast differentiation and function.

Fig 3

Cadm1 loss stimulates osteoclast differentiation and enhances survival and bone-resorption.

(A and B) BMMs from wild-type or Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days and then stained for TRAP (A) or evaluated by real-time PCR for expression of the indicated osteoclast markers (B). TRAP+ multinucleated cells (MNCs) containing more than three nuclei were counted as osteoclasts. Data represent mean number of osteoclasts ± SD (n.s., not significant; n = 3). Bar, 100 μm. Data represent mean Nfatc1, Cathepsin K (Ctsk), acid phosphatase 5, tartrate resistant (Acp5) or dendritic cell-specific transmembrane protein (Dc-stamp) expression relative to that of β-actin ± SD (B, **P < 0.01; n = 6). (C) BMMs from wild-type or Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days. M-CSF and RANKL were then removed from the medium, and cells were stained with TRAP at indicated times after cytokine withdrawal. Remaining TRAP+ cells were scored as surviving cells. Data represent mean number of surviving cells per well (%) ± SD (*P < 0.05; n = 4). (D) BMMs from wild-type or Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) on dentine slices for 4 days; resorption areas were visualized by toluidine blue staining (left) and the resorption area was scored. Data represent mean resorption area (%) ± SD (**P < 0.01; n = 6).

(A and B) BM<span class="Disease">Ms from wild-type or <span class="Gene">Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days and then stained for TRAP (A) or evaluated by real-time PCR for expression of the indicated osteoclast markers (B). TRAP+ multinucleated cells (MNCs) containing more than three nuclei were counted as osteoclasts. Data represent mean number of osteoclasts ± SD (n.s., not significant; n = 3). Bar, 100 μm. Data represent mean Nfatc1, Cathepsin K (Ctsk), acid phosphatase 5, tartrate resistant (Acp5) or dendritic cell-specific transmembrane protein (Dc-stamp) expression relative to that of β-actin ± SD (B, **P < 0.01; n = 6). (C) BMMs from wild-type or Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days. M-CSF and RANKL were then removed from the medium, and cells were stained with TRAP at indicated times after cytokine withdrawal. Remaining TRAP+ cells were scored as surviving cells. Data represent mean number of surviving cells per well (%) ± SD (*P < 0.05; n = 4). (D) BMMs from wild-type or Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) on dentine slices for 4 days; resorption areas were visualized by toluidine blue staining (left) and the resorption area was scored. Data represent mean resorption area (%) ± SD (**P < 0.01; n = 6).

Cadm1 KO osteoclasts show enhanced expression of adhesion-related factors

Given that <span class="Gene">Cadm1 KO osteoclasts exhibited elevated bone-resorbing activity (Fig 3D), we first analyzed the formation of actin rings, which are cytoskeletal structures essential for the bone-resorbing activity of osteoclasts (Fig 4A). However, our results showed that actin rings were similarly formed in Cadm1 KO and wild-type osteoclasts (Fig 4A). We next analyzed the expression of FAK, Pyk2 and c-Src, signaling molecules implicated in cell adhesion and cytoskeletal organization of osteoclasts [32]. c-Src protein levels as assessed by western blot were equivalent between Cadm1 KO and wild-type osteoclasts, while FAK and Pyk2 levels were elevated in Cadm1 KO osteoclasts (Fig 4B).

Fig 4

Cadm1 ablation enhances bone-resorbing activity of osteoclasts.

(A) BMMs from wild-type or Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days, stained with rhodamine phalloidin to visualize actin protein, and observed under a fluorescence microscope. Bar, 100 μm. (B) Whole cell lysates from wild-type or Cadm1 KO osteoclasts were subjected to western blotting using antibodies against FAK, Pyk2 and Src. Actin protein expression served as an internal control. Protein levels relative to actin were quantified by densitometry and are shown below.

(A) BM<span class="Disease">Ms from wild-type or <span class="Gene">Cadm1 KO mouse were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days, stained with rhodamine phalloidin to visualize actin protein, and observed under a fluorescence microscope. Bar, 100 μm. (B) Whole cell lysates from wild-type or Cadm1 KO osteoclasts were subjected to western blotting using antibodies against FAK, Pyk2 and Src. Actin protein expression served as an internal control. Protein levels relative to actin were quantified by densitometry and are shown below.

Discussion

Epigenetic modifications are critical in the organization of chromatin structur<span class="Disease">es at various levels and therefore regulate gene expression [33]. Among the various epigenetic modifications, histone methylation is associated with both transcriptionally active and repressive chromatin status. The methylated sites in histones H3 or H4 are mainly located in the histone tail (H3K4, H3K9, H3K36 and H4K20) and the center of the nucleosome (H3K79) [34]. In this study, we explored NFATc1 target genes whose histone methylation status at the promoter regions changed from bivalent to monovalent patterns, and we identified Cadm1 gene as a candidate. CADM1 is an immunoglobulin-like cell adhesion molecule that regulates intercellular attachment through homophilic interactions [20, 24]. Recent studies showed that the heterophilic interaction between CADM1 and other molecules also plays a critical role in various types of cells. For example, the attachment and functional interaction between dorsal root ganglia neurons and mast cells are mediated by heterophilic binding between mast cell CADM1 and neuronal nectin-3 [35]. The intracellular domain of CADM1 contains FERM (protein 4.1/ezrin/radixin/moesin)-binding and PDZ-binding motifs, which potentially act as a molecular scaffold to form signaling complexes [36]. Stagi et al. reported that FAK binds to CADM1 independently of PDZ domains, but requires the FERM motif, and is implicated in the morphogenetic activities of growth cones [37]. These studies suggest that CADM1 regulates cell-cell interactions and cytoskeletal organization.

Our findings showed that <span class="Gene">Cadm1 expression was induced by RANKL in BMMs in an NFATc1-dependent manner, and histone modification at its promoter regions changed from bivalent to monovalent patterns in response to RANKL. Osteoclasts differentiated from Cadm1 KO mouse BMMs showed higher expression of osteoclast differentiation markers such as Nfatc1, Ctsk, Acp5 and Dc-stamp than wild-type osteoclasts. In addition, osteoclasts differentiated from Cadm1 KO mouse BMMs showed enhanced bone-resorbing activity and survival. The increased bone-resorbing activity of Cadm1 KO osteoclasts is at least partly due to the increased expression of FAK and Pyk2, which are intracellular signaling molecules that play critical roles in the cytoskeletal organization in osteoclasts [32, 38, 39]. However, the mechanisms by which Cadm1 regulates FAK and Pyk2 expression in osteoclasts remain elusive. Consistent with these in vitro findings, Cadm1 KO mice exhibited reduced bone mass. However, bone resorption parameters such as ES/BS, Oc.S/BS and N.Oc/BS were not different between wild type and KO mice. The reason for this discrepancy is unclear, but it may be because the marked reduction of cancellous bone may hamper the accurate measurement of histomorphometric markers.

It is well <span class="Disease">established that immunoreceptor <span class="Chemical">tyrosine-based activation motif (ITAM) signaling plays a pivotal role in osteoclast differentiation. Both DNAX activating protein of 12 kDa (DAP12) and Fc receptor common γ chain (FcRγ) contain cytoplasmic ITAM motif, and mice lacking DAP12 and FcRγ exhibit severe osteopetrosis due to the lack of osteoclasts [40, 41]. BMMs obtained from DAP12 knock out mouse macrophages undergo osteoclastogenesis in response to RANKL but fail to form actin rings, indicating the role of DAP12 in the cytoskeletal organization as well [42]. It was recently reported that sialic acid binding immunoglobulin-like lectin (Siglec)-15 is essential for the functional osteoclast differentiation. Siglec-15 is associated with DAP12 and regulates osteoclast differentiation through ITAM-mediated signaling pathways [43, 44]. Although the interaction between Cadm1 and DAP12 remains unknown, it is possible that Cadm1 negatively regulates osteoclast differentiation by antagonizing Siglec-15 and DAP12 interaction.

Several cytokin<span class="Disease">es and chemokin<span class="Disease">es induced by RANKL promote osteoclast differentiation, thus forming a positive feedback loop in osteoclastogenesis [45]. Conversely, negative regulators of osteoclastogenesis such as interferon regulatory factor 8 (Irf8) and Maf are downregulated by RANKL through B lymphocyte-induced maturation protein-1 (Blimp-1), which is induced by NFATc1 [45]. Here we demonstrated the possibility that the negative regulator Cadm1 is directly regulated by NFATc1 through epigenetic modifications. Our results may provide a novel mechanism for the fine-tuning of osteoclastogenesis through epigenetic and NFATc1-dependent mechanisms.

Conclusions

<span class="Gene">Cadm1 expression is induced by changes in epigenetic modification and by NFATc1 in osteoclasts following RANKL stimulation and serves to inhibit osteclastogenesis.

BMMs from wild-type or cadm1 KO mice were cultured in the presence of M-CSF (50 ng/ml) and RANKL (25 ng/ml) for 4 days.

The cells were stained for <span class="Gene">Nfatc1 using <span class="Species">mouse anti-NFATc1 antibody (mouse monoclonal antibody; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) followed by Alexa546-conjugated goat anti-mouse IgG (Invitrogen, Carlsbad, CA, USA). DAPI (Wako Pure Chemicals Industries, Osaka, Japan) was used for a nuclear staining. Nfatc1 was visualized in red, DAPI was double-labeled in blue, and merged images were shown. Bar = 100 μm.

(TIF)

Click here for additional data file.